Literature DB >> 15231669

Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry.

Travis W Young1, Fang C Mei, Gong Yang, Jennifer A Thompson-Lanza, Jinsong Liu, Xiaodong Cheng.   

Abstract

Cellular transformation is a complex process involving genetic alterations associated with multiple signaling pathways. Development of a transformation model using defined genetic elements has provided an opportunity to elucidate the role of oncogenes and tumor suppressor genes in the initiation and development of ovarian cancer. To study the cellular and molecular mechanisms of Ras-mediated oncogenic transformation of ovarian epithelial cells, we used a proteomic approach involving two-dimensional electrophoresis and mass spectrometry to profile two ovarian epithelial cell lines, one immortalized with SV40 T/t antigens and the human catalytic subunit of telomerase and the other transformed with an additional oncogenic ras(V12) allele. Of approximately 2200 observed protein spots, we have identified >30 protein targets that showed significant changes between the immortalized and transformed cell lines using peptide mass fingerprinting. Among these identified targets, one most notable group of proteins altered significantly consists of enzymes involved in cellular redox balance. Detailed analysis of these protein targets suggests that activation of Ras-signaling pathways increases the threshold of reactive oxidative species (ROS) tolerance by up-regulating the overall antioxidant capacity of cells, especially in mitochondria. This enhanced antioxidant capacity protects the transformed cells from high levels of ROS associated with the uncontrolled growth potential of tumor cells. It is conceivable that an enhanced antioxidation capability may constitute a common mechanism for tumor cells to evade apoptosis induced by oxidative stresses at high ROS levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231669     DOI: 10.1158/0008-5472.CAN-04-0222

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growth.

Authors:  Kurt W Fisher; Binita Das; Robert L Kortum; Oleg V Chaika; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

2.  Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

Authors:  Travis Young; Fang Mei; Jinsong Liu; Robert C Bast; Alexander Kurosky; Xiaodong Cheng
Journal:  Oncogene       Date:  2005-09-08       Impact factor: 9.867

Review 3.  Caveolin-1, a master regulator of cellular senescence.

Authors:  Daniela Volonte; Ferruccio Galbiati
Journal:  Cancer Metastasis Rev       Date:  2020-06       Impact factor: 9.264

4.  Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements.

Authors:  Arvind Ramanathan; Connie Wang; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-19       Impact factor: 11.205

Review 5.  RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.

Authors:  Bingliang Fang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-09-07       Impact factor: 3.848

Review 6.  Proteomics in cancer screening and management in gynecologic cancer.

Authors:  Wei Hu; Weiguo Wu; Ryuji Kobayashi; John J Kavanagh
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

7.  ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.

Authors:  Xiaohua Peng; Varsha Gandhi
Journal:  Ther Deliv       Date:  2012-07

8.  Targeting SOD1 reduces experimental non–small-cell lung cancer.

Authors:  Andrea Glasauer; Laura A Sena; Lauren P Diebold; Andrew P Mazar; Navdeep S Chandel
Journal:  J Clin Invest       Date:  2014-01       Impact factor: 14.808

9.  Models of reactive oxygen species in cancer.

Authors:  Weiqin Lu; Marcia A Ogasawara; Peng Huang
Journal:  Drug Discov Today Dis Models       Date:  2007

Review 10.  Redox regulation of cell survival.

Authors:  Dunyaporn Trachootham; Weiqin Lu; Marcia A Ogasawara; Rivera-Del Valle Nilsa; Peng Huang
Journal:  Antioxid Redox Signal       Date:  2008-08       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.